major psychological and ethical issue for genomic medicine. In this study, we analyzed the
preferences of patients and their families regarding SF and identified the reporting
procedures necessary for informed consent. We interviewed parents of patients with
undiagnosed rare diseases potentially eligible for exome sequencing and patients affected
by the diseases listed in the ACMG recommendations. Four focus groups (FG) were formed …